This inventor holds 1 USPTO granted patent. Top assignee: Gongwin Biopharm Co., Ltd. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Yi-Jhen Feng: Innovator in Pharmaceutical Treatments
Introduction
Yi-Jhen Feng is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mast cell tumors. His innovative approach has led to the development of a unique pharmaceutical composition that holds promise for patients in need.
Latest Patents
Yi-Jhen Feng holds a patent for "Methods for treating mast cell tumors." This patent includes a pharmaceutical composition that features a benzenesulfonamide derivative combined with a pharmaceutically acceptable carrier. The method outlined in the patent provides a new avenue for treating mast cell tumors in subjects requiring such intervention.
Career Highlights
Feng is currently associated with Gongwin Biopharm Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving treatment options for patients suffering from complex medical conditions.
Collaborations
Throughout his career, Yi-Jhen Feng has collaborated with esteemed colleagues, including Chuan-Ching Yang and Mao-Yuan Lin. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Yi-Jhen Feng's contributions to pharmaceutical science, particularly in the treatment of mast cell tumors, highlight his role as a leading inventor in the field. His ongoing work at Gongwin Biopharm Co., Ltd. continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile